COOLER HEADS CARE, INC. — SEC Form D Filing

COOLER HEADS CARE, INC. filed an SEC Form D on July 23, 2026, reporting $3.27M raised in Medical Devices.

Form D filing details

Filing
SEC Form D
Filing date
July 23, 2026
Amount reported
$3.27M
Round stage
Seed
Industry
Medical Devices
Website
https://www.coolerheads.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Many cancer patients experience hair loss due to chemotherapy, which can adds emotional burden to their physical battle against cancer.

Solution

Cooler Heads offers the FDA-cleared Amma™ Scalp Cooling System, a user-friendly and portable device that cools the scalp before, during, and after chemotherapy to reduce hair loss by limiting the amount of chemotherapy drugs reaching hair follicles.

Why now

Advances in medical technology and increased awareness of patient well-being during cancer treatment have created a demand for solutions that address quality-of-life side effects, such as chemotherapy-induced hair loss.

Verdict

Investors backed this at seed out of conviction for market demand for quality-of-life improvements in oncology, not out of belief in novel medical device technology. The implicit bet was on regulatory clearance providing a durable, defensible wedge into a niche with clear patient need. Upside was inherently limited by the specific, non-life-threatening indication and the narrow scope of the initial solution, which constrained revenue per patient and broader clinical application.

Source: SEC EDGAR Form D filing